nefopam has been researched along with mdl 100907 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Coppé, MC; Gillardin, JM; Girard, P; Pansart, Y; Verniers, D | 1 |
1 other study(ies) available for nefopam and mdl 100907
Article | Year |
---|---|
Role of catecholamines and serotonin receptor subtypes in nefopam-induced antinociception.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Analgesics, Non-Narcotic; Animals; Biogenic Monoamines; Catecholamines; Dopamine Antagonists; Drug Interactions; Male; Mice; Mice, Inbred ICR; Nefopam; Nociceptors; Prazosin; Rats; Receptors, Dopamine D1; Receptors, Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists | 2006 |